These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27276260)

  • 1. Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.
    Breitinger U; Farag NS; Ali NKM; Breitinger HA
    Biophys J; 2016 Jun; 110(11):2419-2429. PubMed ID: 27276260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
    Breitinger U; Farag NS; Ali NKM; Ahmed M; El-Azizi MA; Breitinger HG
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33709903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
    Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
    Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
    Griffin S; Stgelais C; Owsianka AM; Patel AH; Rowlands D; Harris M
    Hepatology; 2008 Dec; 48(6):1779-90. PubMed ID: 18828153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.
    Wozniak AL; Griffin S; Rowlands D; Harris M; Yi M; Lemon SM; Weinman SA
    PLoS Pathog; 2010 Sep; 6(9):e1001087. PubMed ID: 20824094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine.
    Castelain S; Bonte D; Penin F; François C; Capron D; Dedeurwaerder S; Zawadzki P; Morel V; Wychowski C; Duverlie G
    J Med Virol; 2007 Feb; 79(2):144-54. PubMed ID: 17177298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
    Foster TL; Verow M; Wozniak AL; Bentham MJ; Thompson J; Atkins E; Weinman SA; Fishwick C; Foster R; Harris M; Griffin S
    Hepatology; 2011 Jul; 54(1):79-90. PubMed ID: 21520195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Study of HCV p7 Channel: Insight into a New Strategy for HCV Inhibitor Design.
    Ying B; Pang S; Yang J; Zhong Y; Wang J
    Interdiscip Sci; 2019 Jun; 11(2):292-299. PubMed ID: 30194627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.
    Griffin SDC; Harvey R; Clarke DS; Barclay WS; Harris M; Rowlands DJ
    J Gen Virol; 2004 Feb; 85(Pt 2):451-461. PubMed ID: 14769903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission.
    Meredith LW; Zitzmann N; McKeating JA
    Antiviral Res; 2013 Dec; 100(3):636-9. PubMed ID: 24157306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.
    Mathew S; Fatima K; Fatmi MQ; Archunan G; Ilyas M; Begum N; Azhar E; Damanhouri G; Qadri I
    PLoS One; 2015; 10(6):e0126510. PubMed ID: 26030803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of viral escape mutations within HCV p7 during treatment with amantadine in patients with chronic hepatitis C.
    Vermehren A; Welsch C; Elsler U; Vermehren J; Herrmann E; Sarrazin C; von Wagner M; Susser S; Hofmann WP; Kronenberger B; Zeuzem S; Mihm U
    Antivir Ther; 2013; 18(6):803-11. PubMed ID: 23824381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
    Steinmann E; Whitfield T; Kallis S; Dwek RA; Zitzmann N; Pietschmann T; Bartenschlager R
    Hepatology; 2007 Aug; 46(2):330-8. PubMed ID: 17599777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
    Mihm U; Grigorian N; Welsch C; Herrmann E; Kronenberger B; Teuber G; von Wagner M; Hofmann WP; Albrecht M; Lengauer T; Zeuzem S; Sarrazin C
    Antivir Ther; 2006; 11(4):507-19. PubMed ID: 16856625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system.
    StGelais C; Tuthill TJ; Clarke DS; Rowlands DJ; Harris M; Griffin S
    Antiviral Res; 2007 Oct; 76(1):48-58. PubMed ID: 17574688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p7 viroporin of the hepatitis C virus contributes to liver inflammation by stimulating production of Interleukin-1β.
    Farag NS; Breitinger U; El-Azizi M; Breitinger HG
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):712-720. PubMed ID: 27979709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of amantadine in mitochondrial dysfunction and oxidative stress mediated by hepatitis C virus protein expression.
    Quarato G; Scrima R; Ripoli M; Agriesti F; Moradpour D; Capitanio N; Piccoli C
    Biochem Pharmacol; 2014 Jun; 89(4):545-56. PubMed ID: 24726442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
    Seiwert SD; Andrews SW; Jiang Y; Serebryany V; Tan H; Kossen K; Rajagopalan PT; Misialek S; Stevens SK; Stoycheva A; Hong J; Lim SR; Qin X; Rieger R; Condroski KR; Zhang H; Do MG; Lemieux C; Hingorani GP; Hartley DP; Josey JA; Pan L; Beigelman L; Blatt LM
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4432-41. PubMed ID: 18824605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target.
    Khaliq S; Jahan S; Hassan S
    Liver Int; 2011 May; 31(5):606-17. PubMed ID: 21457434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.